Journal article
Risk factors for graves' orbitopathy; The australian thyroid-associated orbitopathy research (ATOR) study
JJ Khong, S Finch, C De Silva, S Rylander, JE Craig, D Selva, PR Ebeling
Journal of Clinical Endocrinology and Metabolism | ENDOCRINE SOC | Published : 2016
DOI: 10.1210/jc.2015-4294
Abstract
Context: Previous association studies suggest the development of Graves' orbitopathy (GO) is variably influenced by environmental risk factors. Objective: To determine the risk factors and predict odds for developing GO in Graves' hyperthyroidism (GH). Design: Case-control study. Setting: Multi-centre Australian Thyroid-associated Orbitopathy Research group consisting of tertiary endocrinology and ophthalmology outpatients and related private practices. Patients or Other Participants: A total of 1042 participants with GH were designated as cases if they had GO (n = 604) and controls if they did not have GO (n = 438). Main Outcome Measures: Primary outcome was GO risk factors and secondary ou..
View full abstractGrants
Funding Acknowledgements
This work was supported by an Ophthalmic Research Institute of Australia research grant and the, Australian Postgraduate Award.